Symptoms in advanced cancer: relationship to endogenous cortisol levels
- 1 September 2003
- journal article
- Published by SAGE Publications in Palliative Medicine
- Vol. 17 (6) , 503-508
- https://doi.org/10.1191/0269216303pm780oa
Abstract
We investigated a possible relationship between levels of endogenous cortisol and severity of different symptoms in patients with advanced cancer. Twenty-three patients with predominantly gastrointestinal cancer, recruited in a palliative care unit, entered the study. Urinary free cortisol (UFC) was measured together with demographic data, blood parameters, tumour burden, concurrent illness, medication, nutritional status and quality of life. Significant positive correlations were found between levels of endogenous cortisol and appetite loss, fatigue and nausea/vomiting. The findings support the view of a chronic stress condition in advanced cancer. Interaction between cytokines and the hypothalamicpituitary-adrenal (HPA) axis may also be important in the interpretation of the results.Keywords
This publication has 32 references indexed in Scilit:
- The use of corticosteroids in home palliative care.Supportive Care in Cancer, 2001
- A prospective survey of the use of dexamethasone on a palliative care unitPalliative Medicine, 2001
- Corticosteroids as adjuvant analgesicsJournal of Pain and Symptom Management, 1994
- The Risks and Benefits of Corticosteroids in Advanced CancerDrug Safety, 1994
- Nausea in cancer chemotherapy is inversely related to urinary cortisol excretionBritish Journal of Cancer, 1992
- The use of corticosteroids for symptom management in terminally ill patientsAmerican Journal of Hospice Care, 1990
- Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter studyEuropean Journal of Cancer and Clinical Oncology, 1989
- Methylprednisolone as palliative therapy for female terminal cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Prednisolone as an appetite stimulant in patients with cancer.BMJ, 1984
- Corticosteroid therapy of preterminal gastrointestinal cancerCancer, 1974